Role functioning in Robotic assisted versus laparoscopic liver resection

Organizational Data

DRKS-ID:
DRKS00027531
Recruitment Status:
Recruiting complete, study complete
Date of registration in DRKS:
2022-02-04
Last update in DRKS:
2024-01-05
Registration type:
Prospective

Acronym/abbreviation of the study

Roc'n'Roll

URL of the study

No Entry

Brief summary in lay language

In minimally invasive liver surgery (MILS), robotic-assisted surgery is an emerging speciality which allows surgeons to perform more precise movements with enhanced dexterity and delicate dissection compared to conventional laparoscopic techniques. However, there is currently no randomized controlled trial existing to compare the health-related quality of life (HRQoL) as primary outcome in patients treated by MILS for primary and secondary liver malignancies. The Roc’n’Roll trial aims to compare the postoperative HRQoL during 90 days after surgery after laparoscopic and robotic-assisted liver resections.

Brief summary in scientific language

The current evidence comparing laparoscopic versus robotic liver resections is limited on cohort studies and there is no data extending on HRQoL after robotic surgery. As robotic-assisted surgery might result in a more precise surgery with enhanced recovery of patients and improved HRQoL after liver resection, the present trial aims to compare the HRQoL after robotic-assisted versus laparoscopic liver surgery for primary and secondary liver malignancies.

Health condition or problem studied

ICD10:
C22 - Malignant neoplasm of liver and intrahepatic bile ducts
ICD10:
C78.7 - Secondary malignant neoplasm of liver and intrahepatic bile duct
Healthy volunteers:
No Entry

Interventions, Observational Groups

Arm 1:
Robotic-assisted liver resection
Arm 2:
Laparoscopic liver resection

Endpoints

Primary outcome:
Changes of quality of life measures within 90 days after surgery using the EORTC QLQ-C30 questionnaire "role functioning" item (at postoperative day 30, 60, and 90)
Secondary outcome:
Operating time, Blood loss, Postoperative morbidity and mortality, Conversion rate to open surgery, time-to-functional recovery, Pathological Characteristics, Costs

Study Design

Purpose:
Treatment
Allocation:
Randomized controlled study
Control:
  • Active control (effective treatment of control group)
Phase:
N/A
Study type:
Interventional
Mechanism of allocation concealment:
No Entry
Blinding:
Yes
Assignment:
Parallel
Sequence generation:
No Entry
Who is blinded:
  • Patient/subject

Recruitment

Recruitment Status:
Recruiting complete, study complete
Reason if recruiting stopped or withdrawn:
No Entry

Recruitment Locations

Recruitment countries:
  • Germany
Number of study centers:
Monocenter study
Recruitment location(s):
  • University medical center Department of Surgery, Universitätsmedizin Mannheim, Heidelberg University Medical Faculty Mannheim Mannheim

Recruitment period and number of participants

Planned study start date:
2022-02-20
Actual study start date:
2022-02-14
Planned study completion date:
No Entry
Actual Study Completion Date:
2023-12-18
Target Sample Size:
90
Final Sample Size:
81

Inclusion Criteria

Sex:
All
Minimum Age:
18 Years
Maximum Age:
no maximum age
Additional Inclusion Criteria:
1. Age equal to or greater than 18 years 2. Curative-intent minimally invasive (robotic-assisted or laparoscopic) liver surgery for confirmed or suspected primary or secondary malignancies 3. Written informed consent 4. Ability and willingness to respond questionnaires

Exclusion Criteria

1. ASA ≥ 4 2. Impaired mental state or incompetence of understanding the German language (no fluent German language speaker) 3. Expected lack of compliance

Addresses

Primary Sponsor

Address:
Universitätsklinikum Mannheim
Theodor-Kutzer-Ufer 1-3
68167 Mannheim
Germany
Telephone:
No Entry
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
http://www.umm.de
Investigator Sponsored/Initiated Trial (IST/IIT):
Yes

Contact for Scientific Queries

Address:
Universität Heidelberg, Medizinische Fakultät Mannheim, Chirurgische Klinik
PD Dr. Emrullah Birgin
Theodor-Kutzer-Ufer 1-3
68167 Mannheim
Germany
Telephone:
+49 621 383 1501
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry

Contact for Public Queries

Address:
Universität Heidelberg, Medizinische Fakultät Mannheim, Chirurgische Klinik
PD Dr. Emrullah Birgin
Theodor-Kutzer-Ufer 1-3
68167 Mannheim
Germany
Telephone:
+49 621 383 3671
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry

Principal Investigator

Address:
Universität Heidelberg, Medizinische Fakultät Mannheim, Chirurgische Klinik
PD Dr. Emrullah Birgin
Theodor-Kutzer-Ufer 1-3
68167 Mannheim
Germany
Telephone:
+49 621 383 1501
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry

Sources of Monetary or Material Support

Institutional budget, no external funding (budget of sponsor/PI)

Address:
Universitätsklinikum Mannheim
Theodor-Kutzer-Ufer 1-3
68167 Mannheim
Germany
Telephone:
No Entry
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
http://www.umm.de

Ethics Committee

Address Ethics Committee

Address:
Ethik-Kommission II der Universität Heidelberg, Medizinische Fakultät Mannheim
Theodor-Kutzer-Ufer 1-3
68167 Mannheim
Germany
Telephone:
+49-621-38371770
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
http://www.umm.uni-heidelberg.de/forschung/ethikkommission-ii/

Vote of leading Ethics Committee

Vote of leading Ethics Committee
Date of ethics committee application:
2021-11-17
Ethics committee number:
2021-672
Vote of the Ethics Committee:
Approved
Date of the vote:
2022-01-25

Further identification numbers

Other primary registry ID:
No Entry
EudraCT Number:
No Entry
UTN (Universal Trial Number):
U1111-1272-8103
EUDAMED Number:
No Entry

IPD - Individual Participant Data

Do you plan to make participant-related data (IPD) available to other researchers in an anonymized form?:
No
IPD Sharing Plan:
No Entry

Study protocol and other study documents

Study protocols:
No Entry
Study abstract:
No Entry
Other study documents:
No Entry
Background literature:
No Entry
Related DRKS studies:
No Entry

Publication of study results

Planned publication:
No Entry
Publikationen/Studienergebnisse:
No Entry
Date of first publication of study results:
No Entry
DRKS entry published for the first time with results:
No Entry

Basic reporting

Basic Reporting / Results tables:
No Entry
Brief summary of results:
No Entry